ACLA News

  • With the help of clinical labs, “The Fight Is In Us” aims to boost convalescent plasma donations nationwide

    July 30, 2020
    ACLA member laboratories have been committed from the earliest stages of this pandemic to do everything possible to support the fight against COVID-19, performing nearly 27 million molecular tests for the virus while pioneering a wide range of innovative approaches to meet testing demand. As part of our ongoing work to support public health partners, ACLA is proud to support efforts to significantly increase donations ofContinue Reading »...
  • ACLA Statement on Senate Republicans’ Coronavirus Relief Package

    July 27, 2020
    WASHINGTON, D.C. — Following the release of Senate Republicans’ coronavirus relief package, ACLA President Julie Khani issued the following statement: “ACLA is currently reviewing the Senate Republicans’ coronavirus relief package. At a time when the country is focused on protecting millions of people who are returning to work and school, Americans need a clear federal standard on coverage for testing performed for return-to-work, return-to-school,Continue Reading »...
  • Patients, Employers, Labs and Health Insurance Providers Call on Congress to Dedicate Funding for COVID-19 Testing to Get America Back to Work and School

    July 22, 2020
    WASHINGTON, D.C. – The National Consumers League, the American Clinical Laboratory Association (ACLA) and America’s Health Insurance Plans (AHIP) joined nearly 50 leading stakeholders representing patients, employers, clinical laboratories, health insurance providers and other leaders from across health care community yesterday in sending a letter to congressional leadership requesting dedicated federal funding for the critical testing needed to reopen the country. “Every American, especiallyContinue Reading »...
  • ACLA Letter to HHS on Data Reporting

    June 25, 2020
    ...
  • ACLA Statement on HEROES Act

    May 12, 2020
    WASHINGTON, D.C. — Following the introduction of the ‘‘Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act” ACLA President Julie Khani issued the following statement: “ACLA is currently reviewing the HEROES Act. As noted in our letter to Secretary Azar last month, direct federal funding for laboratories performing COVID-19 testing is critical to achieve our nation’s testing goals. As labs across the country plan for the large capital expensesContinue Reading »...
  • ACLA Statement on CARES Act

    March 25, 2020
    WASHINGTON, D.C. – Following the release the Coronavirus Aid, Relief, and Economic Security Act this evening, ACLA President Julie Khani released the following statement: “For the third time, Congress has failed to provide the necessary funds to support ‘free testing’ for all Americans. Our members remain in an untenable situation, absorbing growing, uncompensated costs for testing specimens with no assurance that they will be appropriately or fairlyContinue Reading »...
  • With Congress on its third financial relief package, policymakers fail to recognize critical role of labs

    March 23, 2020
    WASHINGTON, D.C. — As policymakers close in on a third financial relief package, ACLA President Julie Khani issued the following statement: “We are on the cusp of the U.S. Congress finalizing a third legislative financial relief package to address the coronavirus response.  It is disappointing and alarming that Congress has not yet recognized the contributions of the lab industry and its response during this publicContinue Reading »...
  • ACLA Statement on Senate COVID-19 Response Effort

    March 22, 2020
    WASHINGTON, D.C — Following the release of the latest Senate legislation in response to the COVID-19 pandemic, ACLA President Julie Khani released the following statement: “We are alarmed by the latest Senate proposal – it fails to clearly designate essential emergency funding for expanded testing capacity and laboratory operations. If this legislation moves forward, it would set up commercial laboratories to perform COVID-19 testing atContinue Reading »...
  • Facing Unprecedented Demand for Testing, Clinical Labs Ask Congress for Surge Capacity Fund

    March 19, 2020
    WASHINGTON, D.C. — As commercial laboratories rapidly extend considerable resources to meet demand for COVID-19 testing, ACLA President Julie Khani sent a letter to congressional leadership seeking support from the federal government. “We are growing increasingly concerned that the federal government is not recognizing the strain on the laboratory industry to meet the demand for testing for COVID-19,” writes Khani. As policymakers consider measuresContinue Reading »...
  • Statement on Recent FDA Actions To Expand COVID-19 Testing

    March 17, 2020
    WASHINGTON, D.C. – Following the FDA’s actions announced on March 16, ACLA President Julie Khani released the following statement: “The FDA’s guidance released on Saturday, February 29th cleared the regulatory hurdles to allow commercial labs to immediately begin testing patients as soon as test validation was complete, and our members began accepting specimens for testing less than a week later. The FDA has recently taken several positive steps toContinue Reading »...
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18